microdosing glp-1 research medications are changing how people think about weight loss, diabetes care and even cravings. Now, more people are talking about “microdosing” GLP-1s. That usually means taking less than the typical prescribed Microdosing GLP-1 for Rheumatoid Arthritis:

Challenges of Stopping GLP-1 Treatment Some individuals may wonder how long they need to continue GLP-1 treatments to achieve lasting benefits

Toxicology 209(2):131134

We'd love to hear your thoughts on it

The right support can help you manage side effects and feel better while staying on your care plan

WATCH | WHO recommends GLP-1 therapies for obesity: Health Canada has also listed known risks associated with the use of genuine GLP-1 products, including severe gastrointestinal problems, pancreatitis, worsening kidney injury and low blood sugar, particularly if combined with other medications

Could medications designed for glycemic control also help reduce uric acid levels